Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus

BACKGROUND: Hepatitis C virus-positive (HCV+) kidney transplant (KT) recipients are at increased risks of rejection and graft failure. The optimal induction agent for this population remains controversial, particularly regarding concerns that anti-thymocyte globulin (ATG) might increase HCV-related...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transplantation
Autori principali: Bae, Sunjae, Durand, Christine M., Garonzik-Wang, Jacqueline M., Chow, Eric K. H., Kucirka, Lauren M., McAdams-DeMarco, Mara A., Massie, Allan B., Al Ammary, Fawaz, Coresh, Josef, Segev, Dorry L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534413/
https://ncbi.nlm.nih.gov/pubmed/32433232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002959
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi